Ingevity Corp NGVT

Healthcare SIC 2800 - Chemicals & Allied Products NYSE

Ingevity Corporation provides products and technologies that purify, protect, and enhance the world around us. Through a diverse team of talented and experienced people, we develop, manufacture, and bring to market solutions that are largely renewably sourced and help customers solve complex problems while making the world more sustainable. Our products are used in a variety of demanding applications, including automotive gasoline vapor emissions control systems, food, water and chemical filtration, asphalt paving, agrochemical dispersants, bioplastics, coatings, elastomers, and paint for road markings. We operate in three reportable segments: Performance Materials, Performance Chemicals and Advanced Polymer Technologies.

Last close 70.54 2026-09-04
Market cap $2.43B 2026-06-30 share count
52-week range 45.85 - 79.28

Valuation FY2025 figures against the last close

P/S2.1x
P/E
P/FCF8.9x
EV/EBITDA4.6x
Dividend yield
Diluted EPS-4.61

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $1.17B$1.20B$1.22B$1.67B$1.39B$1.22B$1.29B$1.13B$972.4M$908.3M
Cost of revenue $706.1M$735.3M$770.5M$1.10B$878.7M$750.6M$810.9M$716.8M$643.4M$633.9M
Gross profit $461.5M$464.8M$445.0M$570.1M$512.8M$465.5M$482.0M$416.8M$329.0M$274.4M
R&D $28.4M$24.5M$25.4M$30.3M$26.3M$22.6M$19.7M$21.5M$19.8M$17.6M
SG&A $171.2M$157.8M$161.8M$198.8M$179.3M$149.4M$163.1M$132.4M$106.4M$96.4M
Operating income $418.7M$425.9M$423.2M$452.6M$422.2M$397.9M$396.9M$320.5M$242.7M$163.6M
Interest expense $78.3M$97.8M$93.3M$61.8M$51.7M$47.1M$54.6M$33.2M$18.1M$19.3M
Pre-tax income -$142.1M-$140.5M$130.0M$269.6M$162.8M$235.1M$227.9M$221.8M$174.8M$87.0M
Income tax $8.2M$19.1M$24.2M$58.0M$44.7M$53.7M$44.2M$40.0M$29.6M$42.6M
Net income -$167.1M-$430.3M-$5.4M$211.6M$118.1M$181.4M$183.7M$169.1M$126.5M$35.2M
EPS, basic -4.61-11.85-0.155.542.974.394.394.023.000.83
EPS, diluted -4.61-11.85-0.155.502.954.374.353.972.970.83
Shares, diluted (wtd. avg.) $36.2M$36.3M$36.7M$38.5M$40.1M$41.5M$42.2M$42.6M$42.5M$42.3M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $78.1M$68.0M$95.9M$84.3M$280.7M$260.8M$64.6M$77.8M$87.9M$30.5M
Receivables $148.0M$150.0M$118.9M$100.0M$89.8M
Inventory $186.0M$195.9M$308.8M$335.0M$241.2M$189.0M$212.5M$191.4M$160.0M$151.2M
Total current assets $454.2M$493.2M$658.6M$683.3M$724.9M$628.7M$463.2M$422.7M$368.7M$295.2M
Property, plant and equipment $608.1M$642.9M$762.2M$798.6M$719.7M$703.6M$664.7M$523.8M$438.5M$422.8M
Goodwill $4.3M$175.2M$527.5M$518.5M$442.0M$445.3M$436.4M$130.7M$12.4M$12.4M
Other intangibles $176.1M$278.8M$336.1M$404.8M$337.6M$373.3M$396.2M$125.6M$4.9M$7.3M
Total assets $1.65B$2.02B$2.62B$2.74B$2.47B$2.33B$2.14B$1.32B$929.6M$832.8M
Accounts payable $92.0M$94.5M$158.4M$174.8M$125.8M$104.2M$99.1M$92.9M$83.1M$79.2M
Short-term debt $47.1M$61.3M$84.4M$900.0K$19.6M$26.0M$22.5M$11.2M$9.4M$7.5M
Total current liabilities $341.3M$264.1M$362.9M$303.5M$268.9M$223.4M$215.5M$183.3M$153.2M$136.9M
Total liabilities $1.62B$1.83B$1.99B$2.04B$1.80B$1.69B$1.61B$976.5M$651.7M$698.2M
Retained earnings $404.9M$572.0M$1.00B$1.01B$796.1M$678.0M$497.2M$313.5M$142.8M$16.0M
Total equity $29.7M$195.2M$631.4M$698.3M$673.8M$642.1M$530.8M$338.7M$277.9M$134.6M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $331.2M$128.6M$205.1M$313.4M$293.3M$352.4M$275.7M$252.0M$174.3M$127.9M
Depreciation and amortisation $106.4M$108.3M$122.8M$108.8M$109.9M$100.2M$85.0M$57.0M$40.4M$38.8M
Stock-based compensation $8.4M$12.3M$12.5M
Capital expenditure $57.7M$77.6M$109.8M$142.5M$103.8M$82.1M$114.8M$93.9M$52.6M$56.7M
Investing cash flow -$57.5M-$79.5M-$77.3M-$551.9M-$138.6M-$110.6M-$658.3M-$414.4M-$58.6M-$126.4M
Financing cash flow -$252.2M-$70.2M-$99.9M$48.1M-$133.1M-$50.2M$369.2M$153.7M-$57.8M-$3.4M
Buybacks $56.3M$0$92.1M$145.2M$109.4M$88.0M$6.4M$47.4M$6.6M$0

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001653477-26-000014.

Others in SIC 2800

TickerCompanyMarket capP/ERevenue growth
SOLS Solstice Advanced Materials Inc. $10.12B 42.8x 3.1%
PRM Perimeter Solutions, Inc. $5.20B 16.4%
IOSP INNOSPEC INC. $2.31B 20.1x -3.7%
CC Chemours Co $2.30B 0.4%
OLN OLIN Corp $1.98B 3.7%
HUN Huntsman CORP $1.69B -5.8%
FMC FMC CORP $1.62B -18.3%
ECVT Ecovyst Inc. $1.12B 20.9%